AI Science Tracker

Antibody design across observed and forecasted antigenic evolution

Stanford University · 13 Nov 2026 · biology

Discovery

Antibody design across observed and forecasted antigenic evolution

The Germinal Multi preprint abstract reports antibodies designed against several antigen variants at once. Experimental screens of tens of designs per campaign found binders to resistance-associated EGFR variants and neutralizers of historical SARS-CoV-2 variants, including variants withheld from design. Redesign of BD55-1205 restored neutralization of a forecast-guided engineered escape variant while retaining parental-variant activity. The escape result concerns an engineered variant, not a demonstrated future circulating strain. Review is limited to the abstract and original-server metadata.

Technology: Germinal Multi (computational antibody design framework); evolutionary forecasting model

Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Preprint
  • Test type: direct test
  • Tested: Tens of designs per campaign were screened experimentally; designs bound EGFR variants and neutralized SARS-CoV-2 variants, including variants withheld from the design process.
  • Still unknown: Review limited to the indexed abstract and publication metadata; full-paper methods and additional limitations were not assessed.
  • AI role: Germinal Multi computationally optimized one antibody paratope against multiple antigen variants, and an evolutionary forecasting model guided construction of an escape variant and antibody redesign.

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI%3A%2210.64898%2F2026.11.10.765734%22&resultType=core&format=json · https://api.biorxiv.org/details/biorxiv/10.64898/2026.11.10.765734

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.